File HF4230 ("Health plans must cover metabolic disease treatment") is before the Minnesota Legislature and has not been decided. Latest step (March 12, 2026): Introduction and first reading, referred to.
Minnesota file HF4230, before the Minnesota Legislature. Still to be decided as of 2026-03-12.
Affected patients gain guaranteed access to treatments Minnesotans with inherited metabolic diseases (such as phenylketonuria, maple syrup urine disease, and similar conditions) will no longer face insurance denials for medically necessary treatments, ensuring continuous access to therapies that manage or prevent serious health complications.
Insurance costs may shift across the market Health insurers will absorb treatment costs currently borne by patients or public programs, which may result in modest premium increases spread across all covered members or adjustments to plan designs.
Health plans required to cover treatment of inherited metabolic diseases.
Read the official record for HF4230
See everything up for a vote · This week in Minnesota · See what we have filed with the clerk